Clinical Trial Update: Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics study of a dipeptidyl peptidase-4 inhibitor in Type 2 diabetes mellitus has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: The Catholic University of Korea | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2015-12-14